Related Experiment Video
Updated: Jul 16, 2026

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
Published on: November 3, 2014
Colorectal Cancer Cell's Weapon: RNF32 Engages SPP1+ Macrophages to Foster Liver Metastasis, Targeted by
Hongyu Wang1, Shipeng Dai1, Yuchen Xie1
1Hepatobiliary Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Liver Transplantation, Chinese Academy of Medical Sciences, NHC Key laboratory of Hepatobiliary cancers, Nanjing, 210036, China.
Abstract:
Colorectal cancer liver metastasis (CRLM) involves complex molecular mechanisms. By integrating The Cancer Genome Atlas (TCGA) data and employing Cox regression, Weighted Gene Co-expression Network Analysis (WGCNA), and single-cell RNA sequencing, this study identifies RNF32 as a key gene linking poor prognosis to metastasis. Functional assays demonstrate that RNF32 promotes tumor cell proliferation, invasion, and epithelial-mesenchymal transition (EMT) in vitro, and drives tumor growth and liver metastasis in vivo. Mechanistically, RNF32 catalyzes K48-linked ubiquitination at the K60 site of GSK3β, stabilizing β-catenin and activating the Wnt signaling pathway, thereby upregulating CCL2. Mass cytometry and other experiments further reveal that RNF32 recruits SPP1+ macrophages via CCL2 to remodel the metastatic niche, a process dependent on the CCR2/FABP1/PPARG axis. Macrophage depletion abrogates metastasis, while the FABP1 inhibitor orlistat reverses SPP1 upregulation in macrophages. Moreover, SPP1+ macrophages interact with tumor cell CD44, synergizing with RNF32 to enhance cancer stemness via Wnt signaling. Importantly, virtual screening identifies indole-3-acetic acid (IAA) as an RNF32 inhibitor that suppresses liver metastasis and reverses immunosuppression in vivo. This study establishes RNF32 as a dual-functional driver of metastasis and proposes IAA as a promising therapeutic agent, offering new hope for targeting both tumor-intrinsic EMT and the immune microenvironment in CRC liver metastasis.
Insights
Researchers identified RNF32 as a key gene in colorectal cancer liver metastasis (CRLM). RNF32 promotes tumor growth and metastasis by influencing the Wnt pathway and immune cells, with indole-3-acetic acid (IAA) showing therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- Colorectal cancer liver metastasis (CRLM) is a complex process with poorly understood molecular drivers.
- Identifying key genes and pathways is crucial for developing effective therapeutic strategies against CRLM.
Purpose of the Study:
- To identify novel molecular targets in CRLM.
- To elucidate the mechanisms by which these targets promote metastasis.
- To explore potential therapeutic interventions for CRLM.
Main Methods:
- Integration of The Cancer Genome Atlas (TCGA) data.
- Cox regression, Weighted Gene Co-expression Network Analysis (WGCNA), and single-cell RNA sequencing.
- In vitro and in vivo functional assays, mass cytometry, and virtual screening.
Main Results:
- RNF32 was identified as a key gene promoting tumor proliferation, invasion, and epithelial-mesenchymal transition (EMT).
- RNF32 stabilizes β-catenin, activates Wnt signaling, upregulates CCL2, and recruits SPP1+ macrophages to the metastatic niche.
- Indole-3-acetic acid (IAA) was identified as an RNF32 inhibitor that suppresses liver metastasis and reverses immunosuppression.
Conclusions:
- RNF32 is a critical driver of colorectal cancer liver metastasis through both tumor-intrinsic mechanisms (EMT) and modulation of the tumor immune microenvironment.
- The CCR2/FABP1/PPARG axis and SPP1+ macrophage recruitment are key components of the metastatic niche remodeling.
- Indole-3-acetic acid (IAA) represents a promising therapeutic agent for CRLM, targeting both tumor progression and immune evasion.
More Related Videos
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Renewal of Intestinal Stem Cells
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease

